세계의 제약용 유리 바이알 및 앰풀 시장 예측(-2032년) : 제품별, 재료별, 용량별, 용도별, 최종 사용자별, 지역별 분석

According to Stratistics MRC, the Global Pharmaceutical Glass Vials and Ampoules Market is accounted for $15.8 billion in 2025 and is expected to reach $28.6 billion by 2032 growing at a CAGR of 8.9% during the forecast period. Pharmaceutical glass vials and ampoules are specialized containers used to store and transport liquid and powdered medications in the pharmaceutical industry. Vials are small, cylindrical bottles with a flat bottom and a rubber stopper or screw cap, commonly used for injectable drugs and vaccines. Ampoules are sealed glass containers that hold a single dose of sterile injectable medicine and must be broken open to access the contents. Both are made from high-quality borosilicate or soda-lime glass to ensure chemical stability, durability, and resistance to thermal shock, protecting drug efficacy and preventing contamination.

According to the Indian Drug Manufacturers' Association (IDMA), Gujarat contributes to about 33% of the country's pharmaceutical production.

Market Dynamics:

Driver:

Rising Demand for Biopharmaceuticals and Injectable Therapies

The rising demand for biopharmaceuticals and injectable therapies is significantly boosting the pharmaceutical glass vials and ampoules market. As advanced biologics and personalized medicines gain traction, the need for sterile, secure, and chemically inert packaging grows. Glass vials and ampoules offer excellent barrier properties and compatibility with sensitive formulations, making them ideal for injectable drugs. This surge in biologic drug development and parenteral administration is driving consistent growth and innovation in packaging solutions across the pharmaceutical industry.

Restraint:

High Production and Operational Costs

High production and operational costs in the pharmaceutical glass vials and ampoules market pose significant challenges. These costs arise from expensive raw materials, advanced manufacturing processes, and stringent quality control standards. As a result, manufacturers face pressure to maintain competitive pricing while ensuring product safety and reliability. These factors hinder profitability, limit innovation, and may lead to higher product prices, ultimately affecting accessibility for end-users and reducing market growth potential.

Opportunity:

Technological Advancements

Technological advancements are positively transforming the pharmaceutical glass vials and ampoules market by enhancing product quality, safety, and efficiency. Innovations such as precision forming, improved sterilization techniques, and smart packaging enable better protection of drug integrity and longer shelf life. Automation and digital tracking streamline production and supply chain management, reducing contamination risks and human error. These developments support regulatory compliance and meet growing demand for high-purity, contamination-free packaging in the pharmaceutical industry, ultimately driving market growth.

Threat:

Fragility and Handling Challenges

The pharmaceutical glass vials and ampoules market is facing considerable hurdles due to fragility and handling issues. These containers are prone to breaking during usage, storage, and transit, which can lead to higher expenses, safety hazards, and product loss. Supply chain efficiency is impacted by the complexity of logistics brought on by the requirement for specialized packaging and handling solutions. Consequently, producers are spending money on stronger materials, yet fragility is still a problem.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the pharmaceutical glass vials and ampoules market. The surge in vaccine production and distribution highlighted the critical need for reliable packaging solutions. This led to increased demand for glass vials, prompting manufacturers to scale up production. However, challenges such as raw material shortages, supply chain disruptions, and stringent regulatory requirements posed obstacles. Despite these challenges, the market has seen innovation and investment, driving growth in the sector.

The flint glass segment is expected to be the largest during the forecast period

The flint glass segment is expected to account for the largest market share during the forecast period, due to its excellent clarity, cost-effectiveness, and compatibility with a wide range of drug formulations. Its ability to provide clear visibility of contents ensures better quality control and patient safety, especially for non-sensitive injectable drugs. Moreover, its ease of molding and processing supports scalable production, making it an attractive choice for pharmaceutical manufacturers seeking efficient and reliable packaging solutions.

The biologics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biologics segment is predicted to witness the highest growth rate, due to the high sensitivity and complex storage needs of biologic drugs. These therapies require sterile, non-reactive containers to ensure product integrity, making glass vials and ampoules the preferred choice. Rising investments in biologics and increasing approvals of monoclonal antibodies and gene therapies are boosting demand for premium pharmaceutical glass packaging, fostering innovation in vial design and expanding production capacity across the industry.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share because of Rising demand for injectable drugs, vaccines, and biopharmaceuticals is driving adoption of high-quality packaging solutions, ensuring safety and extended shelf life. Governments' increased healthcare spending and the expansion of pharmaceutical production hubs in countries like India and China further fuel this growth. Additionally, advancements in glass technology promote sustainability and precision, enhancing the overall healthcare ecosystem in the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising demand for safe, reliable drug packaging solutions. The region's strong pharmaceutical manufacturing base, coupled with stringent regulatory standards, ensures high-quality production. Technological advancements and the rise in biologics and injectable drugs are further propelling market expansion. This growth positively impacts public health by enhancing drug stability and safety, while supporting innovation and sustainability efforts within the pharmaceutical packaging industry across North America.

Key players in the market

Some of the key players profiled in the Pharmaceutical Glass Vials and Ampoules Market include Gerresheimer AG, Schott AG, SGD Pharma, Stevanato Group, Nipro Corporation, Corning Incorporated, Shandong Pharmaceutical Glass Co., Ltd., Piramal Glass, Borosil Limited, Ardagh Group, West Pharmaceutical Services, Inc., Bormioli Pharma, Owens-Illinois, Inc., AAPL Solutions Pvt. Ltd., Hindusthan National Glass & Industries Ltd, Accu-Glass LLC, Stoelzle Glass Group and DWK Life Sciences GmbH.

Key Developments:

In May 2025, SCHOTT Pharma and Serum Institute of India (SII) have welcomed TPG Growth as a new strategic partner in their joint venture, SCHOTT Poonawalla. This collaboration marks a significant development in the pharmaceutical packaging sector in India.

In November 2023, SCHOTT and Accelink Technologies, a prominent provider of optical communication solutions, announced a long-term strategic partnership at the China International Import Expo (CIIE) in Shanghai. This collaboration aims to enhance the fiber optic communication supply chain and foster technological advancements in the field.

Products Covered:

• Vials
• Ampoules
• Pre-filled Syringes
• Dropper Bottles

Materials Covered:

• Borosilicate Glass
• Flint Glass
• Polypropylene

Capacities Covered:

• Less than 2ml
• 2ml to 5ml
• 5ml to 10ml
• More than 10ml

Applications Covered:

• Vaccines
• Injectables
• Biologics
• Chemotherapy Drugs
• Oncology Drugs
• Other Applications

End Users Covered:

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Research and Academic Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Vials and Ampoules Market, By Product

• 5.1 Introduction
• 5.2 Vials
• 5.3 Ampoules
• 5.4 Pre-filled Syringes
• 5.5 Dropper Bottles

6 Global Pharmaceutical Glass Vials and Ampoules Market, By Material

• 6.1 Introduction
• 6.2 Borosilicate Glass
• 6.3 Flint Glass
• 6.4 Polypropylene

7 Global Pharmaceutical Glass Vials and Ampoules Market, By Capacity

• 7.1 Introduction
• 7.2 Less than 2ml
• 7.3 2ml to 5ml
• 7.4 5ml to 10ml
• 7.5 More than 10ml

8 Global Pharmaceutical Glass Vials and Ampoules Market, By Application

• 8.1 Introduction
• 8.2 Vaccines
• 8.3 Injectables
• 8.4 Biologics
• 8.5 Chemotherapy Drugs
• 8.6 Oncology Drugs
• 8.7 Other Applications

9 Global Pharmaceutical Glass Vials and Ampoules Market, By End User

• 9.1 Introduction
• 9.2 Pharmaceutical Companies
• 9.3 Biopharmaceutical Companies
• 9.4 Contract Manufacturing Organizations (CMOs)
• 9.5 Research and Academic Institutes
• 9.6 Other End Users

10 Global Pharmaceutical Glass Vials and Ampoules Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Gerresheimer AG
• 12.2 Schott AG
• 12.3 SGD Pharma
• 12.4 Stevanato Group
• 12.5 Nipro Corporation
• 12.6 Corning Incorporated
• 12.7 Shandong Pharmaceutical Glass Co., Ltd.
• 12.8 Piramal Glass
• 12.9 Borosil Limited
• 12.10 Ardagh Group
• 12.11 West Pharmaceutical Services, Inc.
• 12.12 Bormioli Pharma
• 12.13 Owens-Illinois, Inc.
• 12.14 AAPL Solutions Pvt. Ltd.
• 12.15 Hindusthan National Glass & Industries Ltd
• 12.16 Accu-Glass LLC
• 12.17 Stoelzle Glass Group
• 12.18 DWK Life Sciences GmbH